United States Federal Circuit

Reset A A Font size: Print

In Re: Janssen Biotech, Inc., 17-1257

Affirming the rejection of claims for obviousness-type double patenting in the rejection of an attempt to extend the length of an expiring patent through re-application.

Appellate Information

  • Decided
  • Published 2018/01/23

Judges

  • PROST

Court

  • United States Federal Circuit

Counsel